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PlasmodiumPlasmodium falciparum, the aetiological agent of human lethal malaria, is responsible for over 2 million deaths
per year and malaria episodes may vary considerably in their severity and clinical manifestations.
Dysregulated balance of the inﬂammatory response and a defect in the anti-Plasmodium parasite immune
response represent the hallmarks of malaria disease. Among the many possible mechanisms, it is now widely
recognized that the production of pro-inﬂammatory mediators and cytokines and upregulation of endothelial
cell adhesion molecules play important roles in malaria pathogenesis. We and others provided evidence
that some components of allergic inﬂammatory response to malaria parasites or elicited by by-products of
parasite infection may contribute to malaria pathogenesis. This review provides some clue regarding
these mechanisms where mast cells and histamine, an inﬂammatory mediator generated following IgE-
independent or IgE-mediated immune response, were found to play a major role in parasite transmission and
malaria pathogenesis, respectively. This article is part of a Special Issue entitled: Mast cells in inﬂammation.ells in inﬂammation.
+331 44 38 95 21.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Understanding the mechanisms that govern malaria pathogenesis
is a major challenge. Plasmodium falciparum, the aetiological agent of
human lethal malaria, is responsible for over 2million deaths per year.
P. falciparummalaria episodes may vary considerably in their severity
and clinical manifestations. A characteristic feature of malaria is that
the protective immune response is established slowly and only after
the individuals have experienced several rounds of infections. Severe
malaria is complex and probably cannot be represented by one single
pathogenetic scheme, rather a combination of multiple disorders,
including destruction of infected and non infected erythrocytes,
microvascular obstruction, immunopathological and inﬂammatory
processes which collectively account for the pathogenesis.
The medical implications of improved knowledge of immunolog-
ical mechanisms associated with resistance or susceptibility to
malaria disease are numerous and in particular, permit the design of
new therapeutic approaches. The defense mechanisms require
cooperation between cellular and antibody (Ab) immune responses
[1] and involve for example monocytes and antibody-mediated
mechanisms to achieve acquired protective immunity [2]. The
biological properties of Abs produced in response to infection are of
particular importance, since certain isotypes known as cytophilic Abs
can opsonize monocytes and serve for phagocytosis via FcγRI andFcγRII or participate in both antibody-dependent cellular inhibition
(ADCI) as well as antibody-dependent cellular cytotoxicity (ADCC)
[3]. In humans, among IgG subclasses, IgG1 and IgG3 are known to be
protectivewhile IgG2 and IgG4 are considered to be non-protective. In
contrast, the implication of IgE Ab response to parasites in malaria
disease is a subject of controversy and is still a matter of debate. The
allergic nature of malaria disease has been touched upon intermit-
tently over the last 30 years, but has remained either largely fuzzy
(e.g. the beneﬁcial role of anti-histamines) or restricted to single
hypothesis-based approaches (e.g. the controversy on the role of IgE).
Recently a conﬂuence of increasingly compelling data from human
genetic analyses and mouse experimental models suggests for the
ﬁrst time a ﬁrm basis upon which one can develop testable
hypotheses.
Several lines of evidence support the concept that susceptibility to
malaria and atopy may be related to the same immunological defect.
In Ethiopia, atopic children had a higher prevalence of malaria attacks
[4], while in Tanzania maternal malaria had a protective effect on
wheezing in children age of 4 [5]. The role of IgE in clinical and severe
malaria is still poorly documented and results are controversial.
P. falciparum-speciﬁc IgE is elevated in malaria patients and has been
proposed to play a pathogenic role in severe malaria [6–8], whereas,
in asymptomatic individuals, it was associated with protection [9].
Pertinently, explanations for such contradictory results consistently
point to the importance of the individual's genetic background and
the occurrence of polymorphisms in candidate cytokines such as TNF-
α [9,10]. Increased levels of histamine, a major product of allergic
responses derived from basophils and MCs, in plasma and tissue,
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receptor FcεRI, are associated with the severity of disease in humans
infected with P. falciparum and in animal malaria models [11,12].
The adaptation of the hematophagous arthropods (mosquitoes,
sandﬂies, ticks, etc.) to blood feeding is an essential parameter of
host–vector–parasite interactions well exploited by the parasite. Host
skin defenses, which ultimate goal is to prevent successful bloodmeal,
and triggered by salivary components consist of blood leakage,
haemostasis, pain and itch responses, and immune effector mecha-
nisms. The pharmacological properties of saliva [13] may represent
the insect's answer to thesemechanisms. They include anti-coagulant,
anti-platelet, vasodilatory and anti-inﬂammatory/immunosuppres-
sive activities [13,14] which contribute to overcome the host defense
mechanisms. There is now compelling evidence that vectors are not
only syringes injecting parasites, and that co-injected blood-feeding
insect saliva has profound effects on parasite transmission [15,16].
Indeed, Plasmodium berghei sporozoites delivered into mice through
mosquito bites are more infectious than salivary gland extracted
sporozoites injected intravenously, suggesting a facilitating role of
saliva in parasite transmission [17]. To evaluate the effect of mosquito
feeding on the pathogenesis and immune response inmalaria, washed
Plasmodium berghei sporozoites were injected intradermally in the
presence or absence of mosquito feeding. We recently observed that
mice exposed to mosquito feeding in tandem with the inoculation of
sporozoites had higher parasitemias and an elevated progression to
cerebral malaria. This was associated with, in particular, elevated
levels of interleukin-4 and interleukin-10, suppression of overall
transcription in response to infection, and decreased extravasation of
dendritic cells and monocytes [18]. Host tissue reactions to salivary
components following the insect probing and blood feeding vary from
small papules to large pruritic swellings depending on mosquito
species and are reminiscent of allergic responses. These observations
led us to hypothesize that mosquito saliva might exert immunomod-
ulatory effects within a host exposed to mosquito bites through
induction of mast cell degranulation which in turn affects dendritic
cell migration and function. Such amechanism could be of importance
for malaria transmission when sporozoites are present in the
inoculum.
Given the multiple pharmacologic effects of the mosquito saliva,
assessing the immune response to both mosquito saliva and to
mosquito-transmitted Plasmodium infection is of paramount impor-
tance, particularly at the site of inoculation and draining lymph nodes.
Accordingly, this review aims at examining how mosquito saliva
modulates early innate and subsequent antigen-speciﬁc immune
responses. We also discuss the implication of components of allergic
response-associated inﬂammatory response in the pathogenesis of
severe malaria in murine models of cerebral malaria (CM).
2. Anopheles mosquito saliva affects both innate and
antigen-speciﬁc responses under the control of mast cells
Transmission of malaria via infectious bites consists of probing the
skin for blood meal during which sporozoites are inoculated along
with saliva. Saliva which serves not only as a vehicle for sporozoites is
reported to have profound effects by altering the skin homeostasis. In
this respect, it is essential to dissect initial inﬂammatory events that
may determine the outcome of infection and disease pathogenesis.
2.1. Anopheles mosquito bites activate cutaneous mast cells leading to a
local inﬂammatory response and lymph node hyperplasia
Parasite transmission consists of a delivery in the dermis of
sporozoites together with Anopheles saliva. Generally bites of many
insects elicit sensation of pain and itch, but the bite of mosquitoes
causes mainly itch [19,20]. Mosquito bites cause immediate and
delayed local cutaneous reactions and occasionally systemic reac-tions [19–22]. Other studies showed the presence of histamine-
mediated and histamine-independent mechanisms in cutaneous
itching following mosquito bites [23]. In a ﬁrst set of experiments,
we examined to what extent saliva elicits allergic-type inﬂammatory
responses. We reported that Anopheles stephensimosquito bites result
in a local IgE-independent degranulation of skin mast cells as assessed
by a rapid dermal inﬂammation and the hyperplasia of the draining
lymph nodes [24]. This provides a mechanism whereby mosquito
bites may shape the immune response to microorganisms present in
their saliva and inoculated during the blood meal. The sites of
mosquito bites are characterized by ﬂuid extravasation and rapid
inﬁltration with polynuclear neutrophils. This local skin reaction
results from mast cell activation in that: 1) histological analysis of
bitten skin sites shows that mast cells are degranulated and,
2) leukocyte inﬁltration is not observed in the skin of mast cell-
deﬁcient animals unless they are reconstituted with mast cells. Mast
cells are known to induce such local reaction by rapidly releasing
several mediators including granule-associated histamine, tryptase,
TNF-α, MIP-2 as well as eicosanoids, including leukotrienes. A parallel
can be made with a previous work showing that increased plasma
extravasation was induced by mosquito bites in repeatedly immu-
nized mice with Aedes albopictus salivary gland extracts [25].
However, this effect was ascribed to IgE and IgG1-mediated speciﬁc
immune response. In an earlier report, the intradermal injections with
Anopheles albopictus salivary gland extracts in humans showed that a
high molecular weight fraction elicited an immediate and a delayed
response similar to a bite reaction [26]. In our system, the mast cell-
dependent inﬂammatory response at skin sites exposed to Anopheles
stephensimosquito bites occurs in naivemice. This indicates that some
components in Anopheles saliva have the capacity to directly trigger
mast cell activation in the absence of saliva-induced speciﬁc
antibodies. This does not preclude the possibility that repeated
exposures to Anophelesmosquito bites may induce sensitizing speciﬁc
IgE antibodies which may then exacerbate the inﬂammatory
response. The mosquito bite also induced cellular inﬁltrate and
hyperplasia of the draining lymph nodes. These alterations consist of
an increase of the number of various leukocyte lineages including T
lymphocytes, B lymphocytes, dendritic cells, and monocytes/ macro-
phages. The presence of mast cells at the skin site of the mosquito bite
therefore not only controls the local granulocyte inﬂux but also
promotes leukocyte inﬂux in lymph nodes. Accordingly, it has been
reported that peripheral mast cells play a critical role, through TNF-α
they produce, in regulating the hypertrophy of draining lymph nodes
during infection or following activation by the mast cell secretagogue
48/80 [27]. Our data support these ﬁndings in that saliva-induced
activation of dermal mast cells similarly induces lymph node swelling
via the recruitment of T and B lymphocytes, dendritic cells, and
monocytes/macrophages. It must be emphasized that, similar to the
observation made by McLachlan et al. [27], in situ activation of skin
mast cells upon mosquito bites led to the accumulation of TNF-α
within draining lymph nodes. However, in contrast to the ﬁndings
reported by McLachlan et al., using neutralizing TNF-α antibodies we
failed to inhibit lymph node hypertrophy elicited by mosquito bites,
suggesting that other factors may be involved in this process [24]. Our
observation that mosquito bites cause neutrophil inﬁltration only in
mast cell-sufﬁcient mice, clearly demonstrates that neutrophils are
attracted at the site of the mosquito bite by mast cell products, and
could contribute to the host defense against the parasites delivered by
the mosquito. A high molecular weight glycoprotein from Anopheles
stephensi saliva endowedwith a direct neutrophil chemotactic activity
has been observed in vitro [28]. Possibly due to differences in terms of
dose and freshness of saliva mediators, our work in vivo did not
support these observations as mosquito bites failed to induce
neutrophil inﬁltration in mast cell-deﬁcient mice and rather empha-
sizes a critical role of mast cells in the accumulation of neutrophils at
the site of mosquito bite. As the number of mast cells at the site of the
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can argue that saliva does not act as a chemoattractant for mast cells.
Mast cells can serve as a source of TNF-α and the CXC chemokine
macrophage inﬂammatory protein 2 (MIP-2), mediators which have
been implicated in neutrophil recruitment in models of bacterial host
defense and T cell-mediated DTH [29,30]. In a model of contact
hypersensitivity reaction (CHS), MIP-2 protein was found to be
abundant during this inﬂammatory response in and aroundmast cells
of wild-type mice but absent in mast cell–deﬁcient mice [29]. MIP-2
was also shown to be involved in migration of dendritic cells in
contact hypersensitivity (CHS) reaction [31]. The difference in the
requirement of TNF-α in our system and in the system described by
McLachlan et al. [27] may certainly be due to the presence of
particular components within mosquito saliva.
Among further questions that needed to be addressed, it was
important to investigate how mosquito bite-induced mast cell
activation affects antigen-speciﬁc immune responses. Immunosup-
pressive effect mediated bymast cells has been previously reported in
a CHS model in which UVB light induced mast cell degranulation
[32,33]. Do mosquito bites alter the immune response in a similar
way?
2.2. Mast cell-dependent down-regulation of antigen-speciﬁc immune
responses by mosquito bites
During inﬂammatory responses, lymph nodes become the meeting
point between entrapped circulating lymphocytes and antigenpresenting
dendritic cells that have sampled the antigen in the periphery. The
adaptive immune response results from this encounter, and therefore
beneﬁts in terms of rapidity and intensity from the role played by mast
cells in cell migration. It was interesting to examine whether mast cells
also inﬂuence the nature of the immune response. In individuals
sensitized against mosquito saliva and in malaria patients who develop
parasite-speciﬁc IgE [34], these antibodies may increase innate mast cell
responsiveness to mosquito saliva and potentiate their role as sentinels.
Our goal was to understand how saliva facilitates Plasmodium transmis-
sion and to better deﬁne the contribution of skinmast cells in Plasmodium
transmission.
We made the hypothesis that mosquito bites may exert their
immunosuppressive activity through mast cell degranulation elicited
by salivary components. As reported earlier, mosquito bites induce
local mast cell degranulation in the skin [24] with MIP-2 production
[35] which was shown to be a key inﬂammatory cytokine primarily
produced by activated mast cells as demonstrated in a CHS reaction
model [29]. Our results support these ﬁndings in that mosquito bites
induce MIP-2 which production was dependent on the presence of
mast cells [35]. The early induction of MIP-2 in the skin was followed
by a unique production of IL-10 in the draining lymph nodes. The pro-
inﬂammatory activity of MIP-2 in one hand and the immunosuppres-
sive function of IL-10 on the other hand led us to examine the
possibility that these cytokines may affect the ﬁnal outcome of an
antigen-speciﬁc immune response when this antigen was adminis-
tered alongwithmosquito bites. OVA-speciﬁc DTH response, used as a
prototype of T-cell-mediated immune response, was found to be
drastically inhibited in mice exposed to mosquito bites. This
decreased DTH response was reﬂected both by a reduced footpad
swelling as well as by diminished leukocyte recruitment in draining
lymph nodes. Further analysis of cytokine response of OVA-chal-
lenged lymph node cells in vitro demonstrated a signiﬁcantly reduced
IFN-γ (a major cytokine associated with DTH) and elevated IL-10
productions bymosquito bites [35]. These data are compatible with an
immunosuppressive activity of Anopheles saliva on antigen-speciﬁc
immune response. This was emphasized by reduced IFN-γ expression
by antigen-speciﬁc T cells recruited to the skin site of OVA-challenged
footpad of mice exposed to mosquito bites. IL-10 was reported to be
an important regulator of DTH response in that treatment ofsensitized mice with neutralizing anti-IL-10 antibody prolonged the
duration of the hypersensitivity reaction beyond the natural course of
the response [36]. Consistent with these observations, our ﬁndings
show that administration of anti-IL-10 dramatically enhanced IFN-γ
expression (20-fold increase) during DTH response in mice not
exposed to mosquito bites. Similar treatment of mice exposed to
mosquito bites only increased IFN-γ response by approximately 8-
fold, suggesting thatmosquito bites exert a stronger inhibitory control
of DTH response by an IL-10-dependent mechanism. These data
provide strong evidence linking IL-10-mediated down-regulation of
DTH response to mosquito bites. Although it was suspected that IL-10
could be of mast cell origin, this was not ﬁrmly established in this
work. In a previous report, Grimbaldeston et al. reported evidence
that mast cell production of the anti-inﬂammatory cytokine IL-10 can
limit the inﬂammation and tissue damage associated with chronic
low-dose UVB irradiation of mouse skin [37]. More recently, the same
group ﬁrmly established that IL-10 production by cutaneous mast
cells can contribute to the mast cell's ability to suppress inﬂammation
and skin pathology at sites of chronic UVB irradiation in a 1α,25-
dihydroxyvitamin D3/vitamin D receptor-dependent manner [38].
It is well established that mast cells contribute to the development
of DTH reactions [29,39]. In our system, however, we found that
mosquito bites inhibit in a mast cell-dependent manner the induction
of DTH response to an immunogenic antigen injected immediately
after and at the same site as the mosquito bite. A similar
immunosuppressive effect mediated by mast cells has been previ-
ously reported in a CHS reaction model in which UVB light induced
mast cell degranulation [32,33]. During the sensitization phase of DTH
response, dendritic cells capture the antigen, migrate to draining
lymph nodes and undergo a maturation process required for the
activation of naive T cells. We speculate that mosquito saliva induces
the release of a particular set of inﬂammatory mediators by activated
mast cells that may affect the maturation of adjacent dendritic cells
which fail to ultimately elicit fully activated effector T cells. It is known
that the ability of dendritic cells to direct the development of naïve T
cells into Th1, Th2 or regulatory T cells is largely dependent upon the
signals that they receive in the peripheral tissues at the time of
antigen capture. Histamine, which mast cells are the major storage
site, is an attractive candidate as a dendritic cell modulator especially
during early phases of the immune response. Histamine was reported
to have immunosuppressive effects, such as inhibition of polymor-
phonuclear chemotaxis [40] and monocyte IL-12 secretion [41], as
well as induction of IL-10 production [41]. Interestingly, analysis of
cytokine production by cultured lymph node cells after completion of
DTH response indicates that increased production of IL-10 by
mosquito bites was correlated with the presence of mast cells.
Hence, it was tempting to explore if histamine had any role in malaria
pathogenesis.
3. Role of histamine-mediated signaling in the pathogenesis of
severe malaria in mice
The above mentioned results led us to hypothesize that allergic
response-associated inﬂammatory reaction inﬂuences the course of
infection with Plasmodium parasites. Earlier reports indicate that
speciﬁc components of the innate immune system, including
eosinophils [42], basophils [43], and mast cells [44], could play
important roles in the pathogenesis of malaria. Increased levels of
histamine in plasma and tissue, derived from basophils andmast cells,
are associated with the severity of disease in humans infected with P.
falciparum and in several animal models of infections with Plasmo-
dium [11,12,45]. In addition, higher levels of IgE, which binds to
basophils and mast cells and can trigger histamine release, are
associated with the severity of infection with P. falciparum [7]. The
effects of histamine are exerted through three classical G protein-
coupled histamine receptor subtypes, designated H1R, H2R, and H3R,
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recently identiﬁed fourth member of the histamine receptor family,
H4R [47]. Histamine also modulates several biological functions of
vascular endothelial cells. During an acute inﬂammatory response, the
histamine-induced increase of P-selectin (CD62P) expression on
endothelial cells mediates the initial recruitment of inﬂammatory
cells, including neutrophils, from the blood [48]. In vascular
endothelial cells, H1R stimulation leads to several cellular responses
including the release of nitric oxide [49] and enhances vascular
permeability, particularly in postcapillary venules as a result of
endothelial cell contraction [50,51]. Several of these effects of
histamine might be exploited by Plasmodium parasite to survive in
its mammalian host. The increase in vascular permeability appears to
be a component of malaria pathogenesis and could be advantageous
for the parasites, as sporozoites or blood-stage parasites, since it
facilitates their entry and exit from blood vessels. The vasodilatory
effects of histamine might promote spread of the parasite through the
vasculature. In a follow up study, we assessed the relevance of
histamine in malaria pathogenesis and its association with disease
severity.
3.1. H1R- and H2R-mediated signaling play a role in the pathogenesis of
infection with Plasmodium berghei (Pb)
We evaluated the hypothesis that the histamine signaling during
infection with Plasmodium results in an inﬂammatory process that
exacerbates disease by inducing immunopathology or by facilitating
the dissemination, adherence and sequestration of parasites in tissues.
The implication of histamine was examined by using a murine model
of cerebral malaria (CM). This disease model consists of the infection
of a susceptible C57BL/6 mouse strain with the Pb ANKA parasite
strain. Neurological signs followed by death occur between 6 and 11
days post-infection. Using this model, and based on divergent
approaches using H1R−/− and H2R−/− mice, anti-histamine drugs,
and histamine-deﬁcient mice, we demonstrated that histamine
signaling was associated with the severity of disease [52].
The mechanisms by which histamine contributes to disease
severity and at which stage of the parasite life cycle they operate is
unclear. Mice genetically deﬁcient in H1R and H2R as well as mice
treated with H1 and H2 anti-histamines have delayed mortality as
compared to similarly infected wild-type mice untreated with the
anti-histamines, suggesting that production and binding of histamine
to these two receptors are deleterious to the host [52].
3.2. Susceptibility to infection with Pb ANKA is associated with the HDC
gene
To unequivocally determine the effect of histamine on the course
of infection with Plasmodium, histidine decarboxylase-knock out
(HDC−/−) mice were used. HDC−/− mice infected via mosquito bites
with Anopheles stephensi female mosquitoes harboring the Pb ANKA
parasite, a strain which causes CM in the susceptible C57BL/6 mouse
strain, although they eventually succumbed from the infection, they
died at much later times than similarly infected control C57BL/6 mice
and did not exhibit any signs of CM [52]. These data implicate
histamine in progression to CM, and suggest that histamine signaling
could lead to enhanced immunopathological responses. Importantly,
results showing comparable parasitemia between groups infected
with parasites from the Pb ANKA strain do not support the possibility
that the inability of histamine-free mice to develop CM resulted from
reduced parasite burden.
In an attempt to better determine at which stage of parasite
development histamine mediates its adverse effects, HDC−/− mice
were also infected with Pb ANKA-parasitized red blood cells thus
bypassing the pre-erythrocytic phase. Identical to what was observed
following infectious mosquito bites, histamine-free mice did notdevelop CM and survived signiﬁcantly longer than similarly infected
control C57BL/6 mice [52]. These data indicate that although
histamine is produced during all stages of infection with Plasmodium
parasites (i.e. by histamine-producingmast cells in the skin and in the
liver during the pre-erythrocytic stage of parasites development, and
by histamine-producing basophils in the blood where infected red
cells circulate), the pathogenic effects of histamine are likely
prevailing in the latter stages of infection. However, the possibility
that histamine also plays a role in the skin and/or the liver during the
initial phases of the infection cannot be excluded. Indeed, during the
initial phases of the infection, speciﬁcally the pre-erythrocytic stages
of parasite development, histamine release may be triggered in the
dermis when sporozoites are inoculated via mosquito bites. In this
context, Anopheles saliva induces MC degranulation [24]. During later
phases of infection, particularly during the blood stage of parasite
development, histamine production can be elicited from circulating
basophils either via cross-linking of parasite-speciﬁc IgE antibodies or
by the translationally controlled tumor protein (TCTP), a parasite-
derived homolog of the histamine releasing factor (HRF). TCTP has
been found in the plasma of patients infected with P. falciparum and
was shown to trigger histamine release from basophils and IL-
8 secretion from eosinophils [53]. The existence of a Plasmodium
protein that stimulates histamine release lends support to the
hypothesis that histamine signaling is advantageous to the pathogen,
and thus harmful to the host. These ﬁndings could provide a rational
basis for higher levels of histamine in blood and in tissues during
malaria as a result of the activity of vector- or parasite-derived
constituents. Amplifying the host inﬂammatory response, via hista-
mine signaling, may be a strategy developed by the parasites to create
conditions advantageous for their own survival and persistence. Our
results in HDC−/− mice showed that in the absence of histamine, the
disease severity was signiﬁcantly attenuated. The adverse effect of
histamine was highlighted by the delayed non-CM death from Pb
ANKA resulting from the interruption of histamine signaling. The
reason that infection with Pb ANKA remains lethal in histamine-free
HDC−/− mice remains unclear. It seems plausible that, although
inhibiting histamine signaling may abrogate immunopathology, it
cannot stop the adverse effects of hyperparasitemia. In addition to its
distinctive efﬁciency in producing CM in mice, the possibility exists
that Pb ANKA also elicits inﬂammatory mediators other than
histamine that promote progression of infection even in HDC−/−
mice.
Analogous to these data that reveal the adverse effects of
histamine for the host during infection with Plasmodium, a human
study demonstrated that the concentration of histamine in plasma
was increased by almost 5-fold in children suffering frommalaria [54].
Additionally, in this study higher levels of histamine were observed in
the brains of children with severe malaria as compared to lesser
disease presentations. Among the histamine-associated biological
activities relevant to features predictive of severe CM in humans are
increased intracerebral blood ﬂow [55], increased vascular and blood–
brain barrier permeability [56] and oedema [57]. Strikingly, the
resistance of histamine-deﬁcient mice to CM was clearly identiﬁed by
a preserved blood–brain barrier integrity in contrast to the greatly
increased permeability of the brain vasculature with large clusters of
infected erythrocytes observed in infected C57BL/6 mice.
3.3. Histamine production is associated with overall increase of
inﬂammatory response genes during malaria disease
The possibility exists that the resistance of HDC−/− mice to CM
resulted from an impaired or improved capacity of these mice to
produce some immune mediators in response to infection with Pb
ANKA. Therefore, the levels of expression of various relevant
molecules at the mRNA and protein levels were compared between
HDC−/− and C57BL/6 mice infected with Pb ANKA. Indeed, analysis of
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associated molecules including IFN-γ, IL-6, IL-10, KC, MCP-1, MIP-1α,
CTLA-4, and ICOS, indicates that an inﬂammatory response, although
attenuated, was induced in HDC−/− mice [52]. Several reports
indicate that the CM pathologies seen in mice following infection
with Pb ANKA result from the induced pro-inﬂammatory immune
response. In agreement, IFN-γ which was shown to be implicated in
the pathogenesis of experimental CM [58], reached signiﬁcantly
higher levels in the brain tissue and plasma of CM-sensitive C57BL/6
mice than in HDC−/−mice [52]. Similarly, our results showing higher
levels of IL-6 in the plasma and increased expression of IL-6 tran-
scripts in the brain of CM-sensitive C57BL/6 mice than in HDC−/−
mice were also in agreement with reports showing higher production
of IL-6 in response to TNF-α by endothelial cells of brain capillaries of
mice genetically sensitive to CM development [59]. Our results
showing a lower cerebral expression of IL-10 by HDC−/− mice,
which diverge frommurine CM experiments that suggest a protective
effect for IL-10 in CM [60], yet are in accordance with observations in
humans that showed an increase in IL-10 with CM as compared to
mild malaria patients [61]. IL-4 expression corresponded with CM in
our model, in agreement with previous studies, which demonstrated
that deﬁciency in IL-4 or IL-4 receptor alpha led to higher resistance to
Pb ANKA [62].
In the absence of histamine signaling, profound alterations of the
immune response may also occur. A characteristic feature of CM is the
sequestration of CD8+ and CD4+ T cells in the brain capillaries [63–65].
This was conﬁrmed by results in our study showing a reduced
sequestration of CD8+ and CD4+ T cells in the brain of infected HDC−/−
mice [52]. These data suggest that the histamine produced following
infection with Pb ANKA triggers inﬂammation that leads to the
sequestration of T cells in brain capillaries, a prominent component of
CM pathogenesis.
Several studies reported a crucial role of ICAM-1 in malaria
pathogenesis and, notably, ICAM-1-deﬁcient mice are protected from
CM [66]. In this model, ICAM-1−/− mice survived more than 15 days
despite a similar level of parasitaemia in wild-type and knockout
mice, a phenotype that is comparable to HDC−/− mice. Results from
our studies conﬁrmed the correlation between ICAM-1 expression,Fig. 1. Schematic representation of the pathogenetic events occurring in the brain of Pb ANK
infected mice and were correlated to parasitemia levels. Using multiple approaches, inclu
histamine is directly involved in the increase of blood capillary permeability and disruption
side of the ﬁgure with endothelial cells reinforced by a layer of astrocytes. Molecular (qRt-P
parasites demonstrates that histamine is responsible for the increased synthesis of NO, the
permeability as shown by the Evans blue dye extravasation (right hand side of Fig. 1). This
formation of hemorrhagic lesions containing infected red blood cells. The synthesis and rele
receptor [71]. We recently found that this receptor has a protective effect against CM sinceboth at the protein and transcript levels, and susceptibility to CM. The
low levels of ICAM-1 expression in brain microvascular endothelial
cells in histamine-deﬁcient HDC−/− mice could represent a mecha-
nism leading to the lack of T cell sequestration in the brain capillaries
of these mice. Indeed, histamine has been shown to stimulate
endothelial cells to express ICAM-1 and VCAM-1 [67] and Cetirizine,
an H1-receptor antagonist, has been shown to have anti-inﬂamma-
tory properties through the inhibition of leukocyte recruitment and
activation, and by the reduction of ICAM-1 expression on keratino-
cytes [68] and on conjunctival and nasal epithelial cells [69]. In
concordance with our observation of a predominant role for ICAM-1
as compared to VCAM-1 in malaria pathogenesis, infusion of anti-
ICAM-1 but not anti-VCAM-1mAb prevents cytoadherence of infected
erythrocytes in a P yoelii model of CM [70].
4. Conclusions and perspectives
In this review, we provided some clue on how components of the
allergic response may contribute to Plasmodium parasite transmission
and disease pathogenesis. With regard to the implication of histamine
as a key inﬂammatory product in malaria pathogenesis, a schematic
representation is provided in Fig. 1. Although malaria vaccine
development remains a central and ultimate goal, alternative
chemotherapy-based approaches such as histamine receptor antago-
nists have the potential to be highly valuable. Such treatment could be
part of an integrated control strategy, and also be a useful candidate in
intermittent preventive treatment strategies that target speciﬁc high-
risk groups such as children and pregnantwomen. A therapeutic value
in the treatment of malaria infection is supported by the fact that
antihistaminic drugs such as chlorpheniramine potentiate the anti-
Plasmodium effect of meﬂoquine, quinine or pyronaridine [71].
Furthermore, given the availability of anti-histamines, such treatment
could be implemented rapidly to alleviate the burden of malaria in
endemic areas.
The classical pathway by which histamine is released from its
natural stores, mast cells and basophils, involves IgE/FcεRI complexes.
We can argue that Plasmodium parasite-speciﬁc IgE antibodies
sensitize mast cells and basophils and probably other FcεRI cellsA-infected C57BL/6 mice. Histamine levels were found to be elevated in the plasma of
ding HR blockers, H1R or H2R-KO mice and HDC-KO mice, it was demonstrated that
of the blood–brain barrier (BBB). Intact BBB integrity is represented on the right hand
CR) and histological analyses in the brain taken at day 6 post-infection with Pb ANKA
over-expression of adhesion molecules ICAM-1 and VCAM-1 and increased capillary
leads to the sequestration in the capillary endothelium of CD4 and CD8 T cells and the
ase of histamine, which is also a neurotransmitter, is negatively controlled by the H3R
H3R−/− mice were less resistant to CM as compared to wild-type mice [71].
Fig. 2. Upstream events leading to the initiation of histamine-mediated inﬂammatory events. Our hypothesis is that the bridging of IgE Abs bound to FcεRI expressed on mast cells,
basophils and possibly other inﬂammatory cells such as neutrophils and eosinophils can initiate or amplify this process. Alternatively or concomitantly, the translationally controlled
tumor protein (TCTP) known as a histamine releasing factor (HRF) secreted by Pb ANKA and by many other Plasmodium parasite strains including P. falciparum is able to directly
trigger inﬂammatory responses following activation of basophils.
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other inﬂammatory mediators (Fig. 2). In addition, histamine
releasing factor (TCTP) produced by Plasmodium parasites represents
an alternative mean by which histamine release may occur (Fig. 2).
This review addresses the possibility that IgE-mediated allergic
response or atopy may represent risk factors for developing severe
forms of the disease. Genetic studies have established a linkage of
chromosome 5q31 region to the density of blood P. falciparum
parasites [72,73]. This ﬁnding was borne-out in a murine mouse
model using P. chabaudi as infecting parasite where one quantitative
trait locus for resistance to malaria has been mapped to a region
homologous to the human 5q31-q33 [74]. The 5q31 locus that is
known to contain immune response gene cluster, including the genes
encoding the IL-4, IL-5, and IL-13 cytokines, was shown to be
associated with inﬂammatory diseases including asthma [75,76]. In
addition to this locus, three new regions located on chromosome
5p15-p13 and 13q13-q22 were associated with P. falciparum clinical
malaria attacks and chromosome 12q21-q23 was associated with the
maximum parasite density during asymptomatic carriage were
recently identiﬁed [77]. It is interesting to note that these new three
regions have all been previously found to be linked to asthma/atopy
[78–80]. Further immuno-epidemiological as well as experimental
studies are needed to ﬁrmly establish the nature of the relationship
between allergy/atopy and malaria disease.References
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